• Rhinitis/rhinorrhea (intranasal products)

Omnaris Generic Name & Formulations

General Description

Ciclesonide 50mcg/spray; aqueous nasal spray.

Pharmacological Class


How Supplied

Nasal spray (pump)—12.5g (120 sprays)

Omnaris Indications


Treatment of seasonal allergic rhinitis in patients ≥6yrs old and perennial allergic rhinitis in patients ≥12yrs old.

Omnaris Dosage and Administration


2 sprays in each nostril once daily (200mcg/day).


Seasonal allergic rhinitis: <6yrs: not recommended. ≥6yrs: 2 sprays in each nostril once daily (200mcg/day).

Omnaris Contraindications

Not Applicable

Omnaris Boxed Warnings

Not Applicable

Omnaris Warnings/Precautions


Avoid use in patients with recent nasal ulcers/surgery/trauma until healed. Potential worsening of active tuberculosis; fungal, bacterial, viral, or parasitic infections, or ocular herpes simplex. If exposed to measles or chickenpox, consider immunoglobulin prophylactic therapy. If adrenal suppression exists following systemic corticosteroid therapy, replacement with topical steroids may exacerbate symptoms of adrenal insufficiency. Monitor for hypercorticism and HPA axis suppression (if occur discontinue slowly), and for candida infection and other nasal mucosal changes. Monitor for vision changes or with history of increased intraocular pressure, glaucoma and/or cataracts. Monitor for growth suppression in children. Avoid spraying eyes, or directly onto the nasal septum. Reevaluate if no improvement after 2 weeks (for seasonal allergic rhinitis) and 5 weeks (for perennial allergic rhinitis). Pregnancy. Nursing mothers.

Omnaris Pharmacokinetics

See Literature

Omnaris Interactions


May be potentiated by ketoconazole.

Omnaris Adverse Reactions

Adverse Reactions

Headache, epistaxis, nasopharyngitis, ear pain, pharyngolaryngeal pain.

Omnaris Clinical Trials

See Literature

Omnaris Note

Not Applicable

Omnaris Patient Counseling

See Literature